Are you Matthew James Everly?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 2 invites waiting! - Read the latest clinical news, personalized to your specialty.
Education & Training
University of CincinnatiPharmD, 2003
Publications & Presentations
PubMed
- 42 citationsLong‐term outcomes of eculizumab‐treated positive crossmatch recipients: Allograft survival, histologic findings, and natural history of the donor‐specific antibodiesCarrie A. Schinstock, Andrew Bentall, Byron H. Smith, Lynn D. Cornell, Matthew J Everly
American Journal of Transplantation. 2019-06-01 - 294 citationsIncidence and impact of de novo donor-specific alloantibody in primary renal allografts.Matthew J Everly, Lorita M. Rebellato, Carl E. Haisch, Miyuki Ozawa, K. Parker
Transplantation. 2013-02-15 - 148 citationsThe role of immunoglobulin-G subclasses and C1q in de novo HLA-DQ donor-specific antibody kidney transplantation outcomes.Maria Cecilia S. Freitas, Lorita M. Rebellato, Miyuki Ozawa, Anh Nguyen, Nori Sasaki
Transplantation. 2013-05-15
Office
2038 Corinth Ave
Los Angeles, CA 90025Phone+1 310-896-8609
